This Week in Nature

In this week's Nature Biotechnology, a team from Massachusetts General Hospital reports on the development of a next-generation CRISPR-based gene-editing platform. Monomeric Cas9 nucleases are commonly used to induce the genomic alterations in CRISPR systems, but the researchers note that these often result in unwanted off-target mutations.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

In an against-all-odds twist, a researcher studying exceeding rare FOXG1 mutations discovers her daughter has the syndrome.

An effort by Genomics Medicine Ireland is creating a database of diseases based on the genomics of people in Ireland. It now is looking into the possibility of including Scotland in its work.

In recent weeks, the direct-to-consumer genetics firm has rolled out a health hub where customers can share information concerning 18 common health conditions.

In PLOS this week, new genes associated with prostate cancer risk, genetic patterns in M. bovis, and more.